<DOC>
	<DOCNO>NCT02194985</DOCNO>
	<brief_summary>This open-label extension study intend provide continue treatment migalastat HCl subject Fabry disease complete treatment previous migalastat HCl monotherapy study . The study assess long-term safety effectiveness migalastat HCl subject Fabry disease complete migalastat HCl treatment previous study .</brief_summary>
	<brief_title>Open-Label Extension Study Long-Term Effects Migalastat HCL Patients With Fabry Disease</brief_title>
	<detailed_description />
	<mesh_term>Fabry Disease</mesh_term>
	<mesh_term>1-Deoxynojirimycin</mesh_term>
	<criteria>Subject complete treatment previous study migalastat HCl Age 18 year old Male female participant agree use protocol identify acceptable contraception Subject willing provide write informed consent authorization use disclosure Personal Health Information ( PHI ) Subjects last available estimate glomerular filtration rate ( eGFR ) previous study &lt; 30 mL/min/1.73m2 ; unless measure GFR available within 3 month Baseline Visit ( Visit 1 ) , &gt; 30 mL/min/1.73m2 Subject undergone , schedule undergo kidney transplantation currently dialysis Subject document transient ischemic attack , stroke , unstable angina , myocardial infarction within 3 month Visit 1 Subject clinically significant unstable cardiac disease opinion investigator ( e.g. , cardiac disease require active management , symptomatic arrhythmia , unstable angina , NYHA class III IV congestive heart failure ) Subject history allergy sensitivity AT1001 ( include excipients ) iminosugars ( e.g. , miglustat , miglitol ) Subject require treatment Glyset® ( miglitol ) Zavesca® ( miglustat ) Subjects severe unsuitable concomitant medical condition Subjects clinically significant abnormal laboratory value ( ) clinically significant electrocardiogram ( ECG ) finding baseline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Fabry disease</keyword>
	<keyword>Lysosomal storage disease</keyword>
	<keyword>migalastat HCl</keyword>
	<keyword>AT1001</keyword>
</DOC>